| Ambrose Mgbako, MD | |
|
1 Bay Ave, Montclair, NJ 07042-4837 | |
| (973) 971-5595 | |
| Not Available |
| Full Name | Ambrose Mgbako |
|---|---|
| Gender | Male |
| Speciality | Psychiatry |
| Experience | 52 Years |
| Location | 1 Bay Ave, Montclair, New Jersey |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1629045323 | NPI | - | NPPES |
| 1488902 | Medicaid | NJ |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 2084P0800X | Psychiatry & Neurology - Psychiatry | 25MA06256300 (New Jersey) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Eoh Acquisition Group, Llc | 4082009717 | 10 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
| Entity Name | Behavioral Health Specialist At Highland Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1730410481 PECOS PAC ID: 9436282514 Enrollment ID: O20100727000768 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
| Entity Name | Prospect Eogh Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1760851893 PECOS PAC ID: 9931401437 Enrollment ID: O20151230000154 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
| Entity Name | Prospect Eogh Inc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1578932604 PECOS PAC ID: 9931401437 Enrollment ID: O20151230000407 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
| Entity Name | Eoh Acquisition Group, Llc |
|---|---|
| Entity Type | Part B Supplier - Hospital Department(s) |
| Entity Identifiers | NPI Number: 1760851893 PECOS PAC ID: 4082009717 Enrollment ID: O20220331000358 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ambrose Mgbako, MD Po Box 23831, Newark, NJ 07189-0001 Ph: (973) 971-5595 | Ambrose Mgbako, MD 1 Bay Ave, Montclair, NJ 07042-4837 Ph: (973) 971-5595 |
News Archive
Scientists in the U.S. have found that the daughters of women who took a common anti-miscarriage drug during pregnancy may be facing twice the the normal risk of developing breast cancer.
CAS Medical Systems has announced that it has been awarded two United States Patents for technology used in its Fore-Sight Cerebral Oximeter, which is scheduled for commercial release in late 2006.
Fremont-based Memorial Hospital has officially become a member of the ProMedica system.
A genetic disorder that can cause a fatal rise in body temperature in some patients undergoing general anesthesia may hold the key to a cure for heat stroke, according to research published in the April 4 edition of the journal Cell.
A newly discovered connection between two common prostate cancer treatments may soon make prostate cancer cells easier to destroy. Drugs that could capitalize on the discovery are already in the pipeline, and a clinical trial to test whether the finding could improve treatments for prostate cancer patients could be only a few years away.
› Verified 5 days ago
Dr. David Blady, MD Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 127 Pine St, Montclair, NJ 07042 Phone: 973-743-9555 | |
Dr. John Cooke, M.D. Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 516 Bloomfield Ave, Suite 4, Montclair, NJ 07042 Phone: 973-509-1500 Fax: 973-509-1919 | |
Dr. Bruce P Friedman, M.D. Psychiatry & Neurology Medicare: May Accept Medicare Assignments Practice Location: 207 Inwood Ave, Montclair, NJ 07043 Phone: 973-509-8400 Fax: 973-337-5097 | |
Dr. Laurence Michael Westreich, M.D. Psychiatry & Neurology Medicare: Not Enrolled in Medicare Practice Location: 202 Bellevue Ave, Side Entrance, Montclair, NJ 07043 Phone: 973-509-1444 | |
Marie R Badaracco-apolito, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 88 Norwood Ave, Montclair, NJ 07043 Phone: 973-783-5033 Fax: 973-746-2604 | |
Dr. Paul Vincent Kennedy, MD Psychiatry & Neurology Medicare: Medicare Enrolled Practice Location: 117 Watchung Ave, 2nd Floor, Montclair, NJ 07043 Phone: 973-783-2984 Fax: 973-783-5074 | |
Dr. Edward A Latimer, M.D. Psychiatry & Neurology Medicare: Accepting Medicare Assignments Practice Location: 24 Portland Pl, Montclair, NJ 07042 Phone: 973-744-1880 Fax: 973-746-9575 |